| Effect of dexamethasone in hospitalized patients with COVID-19–preliminary report P Horby, WS Lim, J Emberson, M Mafham, J Bell, L Linsell, N Staplin, ... MedRxiv, 2020.06. 22.20137273, 2020 | 11957* | 2020 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1841* | 2021 |
| Effect of hydroxychloroquine in hospitalized patients with Covid-19 RECOVERY Collaborative Group New England Journal of Medicine 383 (21), 2030-2040, 2020 | 1477 | 2020 |
| Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial PW Horby, M Mafham, JL Bell, L Linsell, N Staplin, J Emberson, ... The Lancet 396 (10259), 1345-1352, 2020 | 809 | 2020 |
| Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group, PW Horby, M Mafham, L Peto, ... Medrxiv, 2021.06. 15.21258542, 2021 | 656* | 2021 |
| Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 399 (10320), 143, 2022 | 323* | 2022 |
| Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial PW Horby, G Pessoa-Amorim, L Peto, CE Brightling, R Sarkar, K Thomas, ... Medrxiv, 2021 | 307 | 2021 |
| Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 400 (10349), 359-368, 2022 | 244 | 2022 |
| Interleukin-8 (CXCL8) production is a signatory T cell effector function of human newborn infants D Gibbons, P Fleming, A Virasami, ML Michel, NJ Sebire, K Costeloe, ... Nature medicine 20 (10), 1206-1210, 2014 | 231 | 2014 |
| Nirsevimab for prevention of hospitalizations due to RSV in infants SB Drysdale, K Cathie, F Flamein, M Knuf, AM Collins, HC Hill, F Kaiser, ... New England Journal of Medicine 389 (26), 2425-2435, 2023 | 85 | 2023 |
| Should the use of probiotics in the preterm be routine? M Millar, M Wilks, P Fleming, K Costeloe Archives of Disease in Childhood-Fetal and Neonatal Edition 97 (1), F70-F74, 2012 | 48 | 2012 |
| Perinatal inflammation influences but does not arrest rapid immune development in preterm babies S Kamdar, R Hutchinson, A Laing, F Stacey, K Ansbro, MR Millar, ... Nature communications 11 (1), 1284, 2020 | 37 | 2020 |
| Use of continuous positive airway pressure during stabilisation and retrieval of infants with suspected bronchiolitis PF Fleming, S Richards, K Waterman, PG Davis, COF Kamlin, J Sokol, ... Journal of Paediatrics and Child Health 48 (12), 1071-1075, 2012 | 33 | 2012 |
| A national survey of admission practices for late preterm infants in England PF Fleming, P Arora, R Mitting, N Aladangady BMC pediatrics 14, 1-4, 2014 | 29 | 2014 |
| Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open … O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet 401 (10387), 1499-1507, 2023 | 24 | 2023 |
| Probiotics for the prevention of surgical necrotising enterocolitis: systematic review and meta-analysis CM Rees, NJ Hall, P Fleming, S Eaton BMJ paediatrics open 1 (1), 2017 | 24 | 2017 |
| Probiotics and necrotizing enterocolitis P Fleming, NJ Hall, S Eaton Pediatric surgery international 31, 1111-1118, 2015 | 23 | 2015 |
| Addressing safety concerns of probiotic use in preterm babies PF Fleming, JE Berrington, SE Jacobs Early human development 135, 72-74, 2019 | 21 | 2019 |
| Historical aspects of probiotic use to prevent necrotising enterocolitis in preterm babies P Jarrett, A Meczner, K Costeloe, P Fleming Early Human Development 135, 51-57, 2019 | 15 | 2019 |
| Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial O Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ... The Lancet Diabetes & Endocrinology 11 (12), 905-914, 2023 | 12 | 2023 |
